Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 16, 2004Angewandte Chemie International Edition

Asymmetric Catalysis in the Pharmaceutical Industry

View Full Paper
Ask AI
Bookmark
Share

Authors

JHJoel M. HawkinsPfizer (United States)TWTimothy WatsonPfizer (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hawkins et al. (2004) studied this question.

synapsesocial.com/papers/69d8ca85270e68ba94bed870https://doi.org/10.1002/anie.200330072
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins1984 · 223 citations
  2. 2Synthesis of Chiral 2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl (BINAP) via a Novel Nickel-Catalyzed Phosphine Insertion1994 · 216 citations
  3. 3Resolution of Racemates: Did You Say “Classical”?1998 · 48 citations
  4. 4The Catalytic Asymmetric Aldol Reaction2000 · 865 citations
  5. 5The Family Approach to the Resolution of Racemates1998 · 204 citations